2019
Anti-Müllerian Hormone and its Predictive Utility in Assisted Reproductive Technologies Outcomes
GRANGER E, TAL R. Anti-Müllerian Hormone and its Predictive Utility in Assisted Reproductive Technologies Outcomes. Clinical Obstetrics & Gynecology 2019, Publish Ahead of Print: &na;. DOI: 10.1097/grf.0000000000000436.Peer-Reviewed Original ResearchAnti-Müllerian hormoneART outcomesOvarian responseAssisted Reproductive Technology OutcomesControlled ovarian stimulationReproductive technology outcomesInformative biochemical markersHyperstimulation risksOvarian stimulationClinical utilitySensitive markerStimulation protocolBiochemical markersReproductive agingTechnology outcomesOutcomesHormonePredictive utilityBest predictorMarkersResponse
2013
Disparities Between Black and White Women in Assisted Reproductive Technology
Tal R, Seifer D. Disparities Between Black and White Women in Assisted Reproductive Technology. 2013, 73-83. DOI: 10.1007/978-1-4614-7548-4_5.ChaptersBlack race/ethnicityLower clinical pregnancyReproductive technologiesUS health care systemHealth care systemAssisted Reproductive TechnologyRace/ethnicityClinical pregnancyPoor outcomeLive birthrateSevere diseaseART outcomesWhite womenCare systemSocioeconomic statusGenetic factorsSuch disparitiesOutcomesPregnancyConfoundersDisparitiesDisease